Humans and other species have suffered adverse health effects thought to result from exposure to environmental chemicals that interact with the endocrine system. A significant portion of these effects have been manifested as decreased reproductive potential - often through their effects in utero leading to abnormal development of the reproductive tract. In humans and rodents these effects have been clearly demonstrated with diethylstilbestrol (DES). HOX genes are highly evolutionary conserved and impart segmental tissue identity during the development of undifferentiated body axes. We have demonstrated that HOX genes play an essential role in reproductive tract development. In the prior funding period we have shown that HOX gene expression is altered in mice after in utero exposure to DES, methoxychlor or bisphenol A. We will continue to use DES as our model endocrine disrupter due to its well characterized effects, however will also include these additional agents in selected experiments. The objective of this proposal is to test the hypothesis that the mechanism by which endocrine disrupters affect the development of the reproductive tract is by altering the epigenetic regulation of HOX gene expression. While the initial regulation is mediated through the estrogen receptor (ER a or (b), persistent defects in HOX gene expression after exposure to endocrine disrupters suggests epigenetic alteration of HOX expression. In this application we will determine the molecular mechanisms that regulate HOXA10 and HOXA11 as well as identify epigenetic modifications that regulate HOX genes in both mice and humans. First we will characterize the 5' and intronic regulatory regions of HOXA10 and HOXA11 and identify transcription factor binding sites. Based on preliminary data, we hypothesize that these regulatory regions are methylated in response to xenoestrogen exposure. We will identify the potential impact of DES induced methylation on transcriptional regulation of these genes. Second, we will define the epigenetic changes that lead to persistent Hox gene alteration in the absence of continued exposure in mice. Finally, we will determine if the molecular mechanism by which endocrine disrupters alter HOX gene expression in mice is conserved in humans. We will examine uterine tissue from women with known in utero DES exposure. We have previously shown that Hox genes are necessary for reproductive tract development and that altered Hox expression leads to developmental or functional alterations. Here we expect to demonstrate that endocrine disrupters alter HOX gene expression and will determine the molecular mechanisms that mediate this regulation. No good model exists to explain the mechanism of both the acute and long term diminished HOX gene expression following endocrine disrupter exposure in utero. We hypothesize that the effects are maintained long after exposure through epigenetic mechanisms such as methylation of HOX genes. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
2R01ES010610-06A1
Application #
7266476
Study Section
Special Emphasis Panel (ZRG1-EMNR-E (02))
Program Officer
Heindel, Jerrold
Project Start
2000-07-01
Project End
2012-03-31
Budget Start
2007-06-01
Budget End
2008-03-31
Support Year
6
Fiscal Year
2007
Total Cost
$350,625
Indirect Cost
Name
Yale University
Department
Obstetrics & Gynecology
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Li, Fei; Alderman 3rd, Myles H; Tal, Aya et al. (2018) Hematogenous Dissemination of Mesenchymal Stem Cells from Endometriosis. Stem Cells 36:881-890
Cho, SiHyun; Mutlu, Levent; Zhou, Yuping et al. (2016) Aromatase inhibitor regulates let-7 expression and let-7f-induced cell migration in endometrial cells from women with endometriosis. Fertil Steril 106:673-80
Jorgensen, Elisa M; Alderman 3rd, Myles H; Taylor, Hugh S (2016) Preferential epigenetic programming of estrogen response after in utero xenoestrogen (bisphenol-A) exposure. FASEB J 30:3194-201
Cho, SiHyun; Mutlu, Levent; Grechukhina, Olga et al. (2015) Circulating microRNAs as potential biomarkers for endometriosis. Fertil Steril 103:1252-60.e1
Doherty, Leo F; Taylor, Hugh S (2015) Leiomyoma-derived transforming growth factor-? impairs bone morphogenetic protein-2-mediated endometrial receptivity. Fertil Steril 103:845-52
Flores, Valerie A; Taylor, Hugh S (2015) The Effect of Menopausal Hormone Therapies on Breast Cancer: Avoiding the Risk. Endocrinol Metab Clin North Am 44:587-602
Zhou, Yuping; Jorgensen, Elisa M; Gan, Ye et al. (2011) Cigarette smoke increases progesterone receptor and homeobox A10 expression in human endometrium and endometrial cells: a potential role in the decreased prevalence of endometrial pathology in smokers. Biol Reprod 84:1242-7
Harman, S Mitchell; Vittinghoff, Eric; Brinton, Eliot A et al. (2011) Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes. Am J Med 124:199-205
Martin, J Ryan; Lieber, Sarah B; McGrath, James et al. (2011) Maternal ghrelin deficiency compromises reproduction in female progeny through altered uterine developmental programming. Endocrinology 152:2060-6
Aldad, Tamir S; Rahmani, Nora; Leranth, Csaba et al. (2011) Bisphenol-A exposure alters endometrial progesterone receptor expression in the nonhuman primate. Fertil Steril 96:175-9

Showing the most recent 10 out of 39 publications